Machine learning models to identify lead compound and substitution optimization to have derived energetics and conformational stability through docking and MD simulations for sphingosine kinase 1
- PMID: 39417979
- DOI: 10.1007/s11030-024-10997-4
Machine learning models to identify lead compound and substitution optimization to have derived energetics and conformational stability through docking and MD simulations for sphingosine kinase 1
Abstract
Sphingosine kinases (SphKs) are a group of important enzymes that circulate at low micromolar concentrations in mammals and have received considerable attention due to the roles they play in a broad array of biological processes including apoptosis, mutagenesis, lymphocyte migration, radio- and chemo-sensitization, and angiogenesis. In the present study, we constructed three classification models by four machine learning (ML) algorithms including naive bayes (NB), support vector machine (SVM), logistic regression, and random forest from 395 compounds. The generated ML models were validated by fivefold cross validation. Five different scaffold hit fragments resulted from SVM model-based virtual screening and docking results indicate that all the five fragments exhibit common hydrogen bond interaction a catalytic residue of SphK1. Further, molecular dynamics (MD) simulations and binding free energy calculation had been carried out with the identified five fragment leads and three cocrystal inhibitors. The best 15 fragments were selected. Molecular dynamics (MD) simulations showed that among these compounds, 7 compounds have favorable binding energy compared with cocrystal inhibitors. Hence, the study showed that the present lead fragments could act as potential inhibitors against therapeutic target of cancers and neurodegenerative disorders.
Keywords: Combinatorial chemistry; Fragment screening; IFP analysis; Machine learning; Molecular docking; Molecular dynamics simulations; SVM; SphKs; Sphingosine kinases.
© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Conflict of interest statement
Declarations. Competing interests: Authors declare no conflict of interest.
References
-
- Alemany R, van Koppen CJ, Danneberg K et al (2007) Regulation and functional roles of sphingosine kinases. Naunyn Schmiedebergs Arch Pharmacol 374:413–428. https://doi.org/10.1007/s00210-007-0132-3 - DOI - PubMed
-
- Gupta P, Taiyab A, Hussain A et al (2021) Targeting the sphingosine kinase/sphingosine-1-phosphate signaling axis in drug discovery for cancer therapy. Cancers (Basel) 13:1898. https://doi.org/10.3390/cancers13081898 - DOI - PubMed
-
- Wang P, Yuan Y, Lin W et al (2019) Roles of sphingosine-1-phosphate signaling in cancer. Cancer Cell Int 19:1–12. https://doi.org/10.1186/s12935-019-1014-8 - DOI
-
- Bonica J, Mao C, Obeid LM, Hannun YA (2020) Transcriptional regulation of sphingosine kinase 1. Cells 9:2437. https://doi.org/10.3390/cells9112437 - DOI - PubMed - PMC
-
- Kleuser B (2018) The enigma of sphingolipids in health and disease. Int J Mol Sci 19:3126. https://doi.org/10.3390/ijms19103126 - DOI - PubMed - PMC
MeSH terms
Substances
LinkOut - more resources
Full Text Sources